Towards evidence-based vitamin D supplementation in infants : vitamin D intervention in infants (VIDI) - study design and methods of a randomised controlled double-blinded intervention study

Show full item record



Permalink

http://hdl.handle.net/10138/188597

Citation

Helve , O , Viljakainen , H , Holmlund-Suila , E , Rosendahl , J , Hauta-alus , H , Enlund-Cerullo , M , Valkama , S , Heinonen , K , Räikkönen , K , Hytinantti , T , Mäkitie , O & Andersson , S 2017 , ' Towards evidence-based vitamin D supplementation in infants : vitamin D intervention in infants (VIDI) - study design and methods of a randomised controlled double-blinded intervention study ' , BMC Pediatrics , vol. 17 , 91 . https://doi.org/10.1186/s12887-017-0845-5

Title: Towards evidence-based vitamin D supplementation in infants : vitamin D intervention in infants (VIDI) - study design and methods of a randomised controlled double-blinded intervention study
Author: Helve, Otto; Viljakainen, Heli; Holmlund-Suila, Elisa; Rosendahl, Jenni; Hauta-alus, Helena; Enlund-Cerullo, Maria; Valkama, Saara; Heinonen, Kati; Räikkönen, Katri; Hytinantti, Timo; Mäkitie, Outi; Andersson, Sture
Contributor: University of Helsinki, Clinicum
University of Helsinki, HUS Children and Adolescents
University of Helsinki, Children's Hospital
University of Helsinki, Clinicum
University of Helsinki, Clinicum
University of Helsinki, Children's Hospital
University of Helsinki, Children's Hospital
University of Helsinki, Department of Psychology and Logopedics
University of Helsinki, Medicum
University of Helsinki, Children's Hospital
University of Helsinki, HUS Children and Adolescents
University of Helsinki, HUS Children and Adolescents
Date: 2017-03-29
Language: eng
Number of pages: 8
Belongs to series: BMC Pediatrics
ISSN: 1471-2431
URI: http://hdl.handle.net/10138/188597
Abstract: Background: Vitamin D is important for bone mass accrual during growth. Additionally, it is considered a requirement for a multitude of processes associated with, for example, the development of immunity. Many countries apply vitamin D supplementation strategies in infants, but the guidelines are not based on scientific evidence and aim at prevention of rickets. It remains unclear whether the recommended doses are sufficient for the wide array of other effects of vitamin D. The VIDI trial performed in Finland is the first large randomised controlled study for evaluation of the effects of different vitamin D supplemental doses in infancy on: 1. bone strength 2. infections and immunity 3. allergy, atopy and asthma 4. cognitive development 5. genetic regulation of mineral homeostasis Methods/Design: VIDI, a randomised controlled double-blinded single-centre intervention study is conducted in infants from the age of 2 weeks to 24 months. Participants, recruited at Helsinki Maternity Hospital, are randomised to receive daily either 10 mu g (400 IU) or 30 mu g (1 200 IU) of vitamin D3 supplementation. Both groups are assessed at 6 months of age for calcium homeostasis, and at 12 and 24 months of age for parameters associated with bone strength, growth, developmental milestones, infections, immunity, atopy-related diseases, and genetic factors involved in these functions. Discussion: The study enables evaluation of short and long term effects of supplemental vitamin D on growth, immune functions and skeletal and developmental parameters in infants, and the effects of genetic factors therein. The results enable institution of evidence-based guidelines for vitamin D supplementation in infancy.
Subject: Allergy
Asthma
Bone development
Cognitive development
Immunity
Infants
Infections
Vitamin D
SERUM 25-HYDROXYVITAMIN D
D DEFICIENCY
EARLY-CHILDHOOD
RESPIRATORY-INFECTIONS
COGNITIVE IMPAIRMENT
D INSUFFICIENCY
CLINICAL-TRIAL
D-RECEPTOR
DAY-CARE
CHILDREN
3123 Gynaecology and paediatrics
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
art_3A10.1186_2Fs12887_017_0845_5.pdf 624.9Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record